商标等待形式审查

NovoCare

Overview

关于老挝商标「NovoCare」，老商通整理了如下公开信息，由 Novo Nordisk A/S 于 2026-01-07 提交申请，当前状态为等待形式审查。标识字段包括：申请号 M/1886982；DIP 编号 LAM1886982；主管局代码 LA；申请类型 Other。时间线要点：公开/公告日 2026-03-06。商品/服务类别（Nice）标注为 35、16、9、41、5、36、42、44。商品与服务说明摘录：Promoting public awareness about medical conditions; online business services in the nature of retail pharmac…。代理机构 / 代理人记载为 Eva Borgen。您可在站内继续浏览同申请人其它知识产权，或经企业详情查看更多关联资产与登记信息。

商标老挝 DIP

申请号 M/1886982

申请日期 2026-01-07

申请人 Novo Nordisk A/S

代理机构 Eva Borgen

类别 35 · 16 · 9 · 41 · 5 · 36 · 42 · 44

图样

下载

基础信息

类型: 商标
申请号: M/1886982
状态: 等待形式审查
申请人: Novo Nordisk A/S
代理机构: Eva Borgen
申请日期: 2026-01-07
公开/公告日: 2026-03-06
国际分类: 35 · 16 · 9 · 41 · 5 · 36 · 42 · 44
商品 / 服务: Promoting public awareness about medical conditions; online business services in the nature of retail pharmacy services for the ordering, purchase, and delivery of pharmaceutical preparations, location of healthcare professional, coordination of direct-to-consumer delivery of medicine.
Instructional and teaching material.
Downloadable software in mobile applications for telehealth and telemedicine offerings for use by patients and healthcare professionals; downloadable software from websites for use by patients and healthcare professionals for the treatment of medical conditions; downloadable software for enabling patients to access general medical, health, and wellness information and advice; downloadable software for management and dispensing of medical prescriptions.
Educational services, namely, educational programmes, online electronic publication of reports, newsletters, and articles, online coaching and training services for patients and healthcare professionals related to the treatment of medical conditions.
Pharmaceutical preparations for the treatment of diabetes and obesity, pharmaceutical preparations for haemostasis management and for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease; pharmaceutical preparations for hormone therapy and stem cells for medical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical preparations for medical use.
Providing financial assistance to patients and healthcare providers for prescription pharmaceutical costs; providing information about patient reimbursement and insurance coverage for pharmaceuticals.
Platform as a service featuring computer software to permit users to identify, request and receive pharmacy products.
Providing information in the field of management of medical conditions; charitable services, namely, patient assistance program to provide pharmaceuticals free of charge to low-income patients without prescription drug coverage.